Agalsidase beta 35mg powder for solution for infusion vials

ID 407801001
Therapeutic MoietyAgalsidase beta
Name Agalsidase beta 35mg powder for solution for infusion vials
Preferred name basisrINN - Recommended International Non-proprietary
Date of name applicability 13 Jan 2009
Previous name Agalsidase beta 35mg powder for solution for injection vials
Basis of previous namerINN - Recommended International Non-proprietary
Reason for name changeOther
Prescribing statusValid as a prescribable product
Dose formDiscrete
Unit dose form size 1.000
Unit dose form unitsvial
Unit dose unit of measurevial
IngredientsAgalsidase beta
Form & Routesolutioninfusion.intravenous
Drug formulationsPowder for solution for infusion
Drug routeIntravenous
Control drugNo Controlled Drug Status